Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER

WEN CHANG TSENG | Medicine and Health Sciences | Best Researcher Award

Mr WEN CHANG TSENG, Cathay General Hospital/Departmentof Radiology, Taiwan

Mr. Wen Chang Tseng is an accomplished medical radiologic technologist and deputy director with extensive expertise in diagnostic radiology and clinical trials. 📡🔬 With a career spanning over two decades (since 1999), he has contributed significantly to medical imaging and radiology, playing a key role in multinational clinical trials on ankylosing spondylitis and rheumatoid arthritis. 🏥 His work in advancing radiological technology has made a substantial impact in medical research, ensuring high standards in diagnostic procedures. 🎯 His dedication to improving patient care through innovative imaging techniques and clinical studies has earned him recognition as a leading expert in his field. 🌍 His contributions to Phase II and Phase III multinational studies highlight his commitment to advancing diagnostic radiology. 📈 His leadership in technology development, combined with his research experience, makes him a deserving recipient of the Best Researcher Award. 🏅👏

Publication Profile

Scopus

Education

Mr. Wen Chang Tseng holds a strong educational background in medical imaging and engineering. 🏛️ He earned his degree from the Department of Medical Imaging and Radiological Technology at Yuanpei University, where he gained in-depth knowledge of radiological sciences and medical imaging techniques. 🏥🔍 Expanding his technical expertise, he further pursued studies in the Department of Electrical Engineering at Chung Yuan Christian University, enhancing his understanding of technological applications in medical diagnostics. ⚡🖥️ His combined knowledge of radiology and electrical engineering allows him to develop and implement cutting-edge imaging solutions for enhanced patient diagnosis and treatment. 🏆 His education has provided a robust foundation for his career in medical radiology, clinical trials, and diagnostic imaging research. 🎯 His multidisciplinary academic training continues to support his innovative contributions to medical technology and radiology advancements. 📡🩻

Experience

With over two decades of experience in the field of diagnostic radiology, Mr. Wen Chang Tseng has been a cornerstone of medical imaging and radiologic technology. 🏆 Since 1999, he has been actively involved in the Diagnostic Radiology Department, applying his expertise in radiological imaging to enhance diagnostic accuracy. 🏥 His dedication and leadership have led him to serve as a Medical Radiologic Technologist and Deputy Director of Technology, where he has played a pivotal role in managing radiological procedures, research coordination, and advanced imaging technologies. 🔬🖥️ His work extends to supervising and conducting multinational clinical trials focusing on ankylosing spondylitis and rheumatoid arthritis. 🌎📊 His contributions have improved clinical imaging protocols and enhanced the reliability of diagnostic techniques. 🎯 His leadership in medical imaging research and development has made a lasting impact on the field of radiology. 🏅👏

Awards & Honors

Mr. Wen Chang Tseng’s contributions to medical imaging and radiological technology have been widely recognized through numerous accolades. 🏆 His expertise in diagnostic radiology and clinical trial research has earned him prestigious honors, including commendations for excellence in radiologic innovation and clinical research advancements. 🌟 As a leader in medical imaging research, he has been an integral part of groundbreaking Phase II and Phase III multinational studies on ankylosing spondylitis and rheumatoid arthritis. 📈 His pioneering role in clinical trials has led to significant improvements in diagnostic imaging standards, contributing to global advancements in radiology. 🌍 He has also been acknowledged by international research institutions for his commitment to technological advancements in radiologic sciences. 🔬 His dedication and innovation make him a distinguished figure in the field, making him a deserving recipient of the Best Researcher Award. 🏅🎯

Research Focus

Mr. Wen Chang Tseng specializes in diagnostic radiology, medical imaging technology, and clinical trial research. 📡 His work focuses on enhancing imaging techniques for ankylosing spondylitis and rheumatoid arthritis through Phase II and Phase III multinational clinical trials. 🏥 He has played a crucial role in advancing radiologic assessment methods, ensuring precise imaging for improved diagnosis and treatment planning. 🎯 His research integrates medical imaging with electrical engineering, allowing for the development of cutting-edge radiologic technologies. 🖥️⚡ His contributions to clinical trials have led to refined imaging protocols, benefiting global healthcare standards. 🌍 His multidisciplinary expertise in radiology and technology has driven innovation in diagnostic procedures, improving efficiency and accuracy in detecting musculoskeletal disorders. 📊 His research continues to shape the future of medical imaging, contributing to better patient care and medical advancements. 🏆

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award